Phospho-GSK-3α/β (Ser21/9) Antibody [N3H2]

카탈로그 번호 F0496

인쇄

생물학적 설명

특이성 Phospho-GSK-3α/β (Ser21/9) Antibody [N3H2]는 Ser21에서 인산화될 때에만 전체 GSK-3α 단백질의 내인성 수준을 검출하며, Ser9에서 인산화될 때에만 전체 GSK-3β 단백질의 내인성 수준을 검출합니다.
배경 Phospho-GSK-3α/β (Ser21/9)는 글리코겐 대사 조절에서의 역할로 원래 확인된 세린/트레오닌 단백질 키나아제 계열인 글리코겐 신타아제 키나아제-3 (GSK-3)의 비활성화된 형태를 나타내며, GSK-3α 및 GSK-3β 두 가지 동형이 유비쿼터스하게 발현됩니다. GSK-3는 촉매 도메인의 프라이밍된 기질 결합 포켓에 대한 접근을 경쟁적으로 억제하는 유사 기질 역할을 하는 핵심 조절 세린 잔기 Ser21 (GSK-3α에) 및 Ser9 (GSK-3β에)를 포함하는 N-말단 영역을 가지고 있습니다. 활성화는 활성화 루프에서 Tyr279 (GSK-3α) 또는 Tyr216 (GSK-3β) 인산화에 추가적으로 의존합니다. GSK-3는 비자극 세포에서 구성적 활성을 유지하지만, 성장 인자, 인슐린 또는 스트레스 요인에 반응하여 PI3K 경로를 통해 활성화되는 Akt와 같은 키나아제에 의한 Ser21/9 인산화를 통해 주로 비활성화되며, 이는 기질 도킹을 차단하고 해당 부위의 C-말단에 4개의 잔기 떨어진 프라이밍 인산화 잔기가 필요한 100개 이상의 표적의 인산화를 중단시킵니다. 이 비활성화는 GSK-3 매개 β-카테닌 분해를 방지하여 글리코겐 합성, 세포 생존, 증식 및 Wnt 신호전달과 같은 과정을 촉진하는 동시에 세포자멸사, 타우 과인산화 (알츠하이머와 관련), 및 사이클린 D1 회전을 억제합니다. PP1, PP2A 또는 PP2B와 같은 포스파타아제에 의한 Ser21/9 탈인산화는 GSK-3를 재활성화하여 조절 이상 시 신경 퇴행, 암 및 대사 장애를 유발합니다.

사용 정보

응용 WB, IP 희석
WB IP
1:1000 1:50
반응성 Human, Mouse, Rat, Monkey
출처 Rabbit Monoclonal Antibody MW 51 kDa, 46 kDa
보관 완충액 PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
보관
(수령일로부터)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

참조

  • https://pubmed.ncbi.nlm.nih.gov/11035810/
  • https://pubmed.ncbi.nlm.nih.gov/25435019/

적용 데이터

WB

Selleck 검증

  • F0496-wb
    Lane 1: COS-7 (λ phosphatase treated), Lane 2: COS-7 (PDGF, 100ng/mL, 5 min)